Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus

US Patent 6046222 · Granted Apr 4, 2000

Estimated economic value: $186,737,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of thiazolidinedione derivatives in the treatment of insulin resistance2000
Use of thiazolidinedione derivatives in the treatment of insulin resistance2000
Use of thiazolidinedione derivatives in the treatment of insulin resistance2000
Use of thiazolidinedione derivatives in the treatment of insulin resistance2000
Use of thiazolidinedione derivatives in the treatment of insulin resistance2000
Use of thiazolidinedione derivatives in the treatment of insulin resistance2000
Use of thiazolidinedione derivatives in the treatment of anovulation, hyperandro1999
Use of thiazolidinedione derivatives in the treatment of anovulation, hyperandro1999
Use of thiazolidinedione derivatives in the treatment of anovulation, hyperandro1999
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndro1999
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndro1999
Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndro1999